FDA Releases Medical Device Cybersecurity Draft Guidance

“Cybersecurity risk management is a shared responsibility among stakeholders…that provide products that are not regulated by the FDA.”

It is important for medical device manufacturers to monitor, identify and address cybersecurity vulnerabilities, according to draft guidance recently released by the Food and Drug Administration (FDA).

The FDA draft guidance is also meant to “inform industry and FDA staff of the Agency’s recommendations for managing postmarket cybersecurity vulnerabilities for marketed medical devices.”  For the full article click here 

from cyber security caucus http://ift.tt/1P35KU2
via IFTTT